Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.260
+0.150 (4.82%)
At close: Mar 9, 2026, 4:00 PM EDT
3.230
-0.030 (-0.92%)
After-hours: Mar 9, 2026, 7:32 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $338.62 million as of March 9, 2026. Its market cap has increased by 20.81% in one year.
Market Cap
338.62M
Enterprise Value
206.97M
1-Year Change
20.81%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $338.62M, an increase of 102.77%. That is a compound annual growth rate of 14.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 297.60M | 36.01% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 338.60M |
| Opus Genetics | 337.23M |
| Adlai Nortye | 328.78M |
| X4 Pharmaceuticals | 328.76M |
| Relmada Therapeutics | 326.33M |
| Avalo Therapeutics | 320.46M |
| Greenwich LifeSciences | 319.90M |
| Protara Therapeutics | 316.16M |